Results 101 to 110 of about 20,284 (182)

CYP2C19*6 Allele [PDF]

, 2020
openaire   +1 more source

CYP2C19*2 Allele [PDF]

, 2020
openaire   +1 more source

CYP2C19*5 Allele [PDF]

, 2020
openaire   +1 more source

Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressants. [PDF]

Pharmacogenomics J
Hajto J, Piechota M, Krätschmer I, Konowalska P, Boyle GE, Fowler DM, Borczyk M, Korostynski M.   +7 more
europepmc   +1 more source

CYP2C19*4 Allele [PDF]

, 2020
openaire   +1 more source

Genetische Determinanten der Clopidogrel-Response - Untersuchungen zu CYP2C19*2 und CYP2C19*17 [PDF]

, 2017
Nach einer Koronarintervention erhalten Patienten eine duale antithrombozytäre Therapie mit ASS und Clopidogrel um das peri- und postinterventionelle Risiko thrombotischer Komplikationen zu reduzieren. Für Clopidogrel ist das individuelle Ansprechen auf die Behandlung jedoch nicht einheitlich.
openaire  

Sesamin exhibits potential food-drug interactions through the inhibition of cytochrome P450s and human UDP-glucuronosyltransferases <i>in vitro</i>. [PDF]

RSC Adv
Yin H, Zhu L, Wang X, Wang Z, Wang H, Liu Y.   +5 more
europepmc   +1 more source

CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy. [PDF]

Eur J Clin Pharmacol
Kasolo Y, Burford E, Obeidat M, Beaman GM, Monk T, Bastiaenen R, Newman WG, Cooper RM.   +7 more
europepmc   +1 more source

CYP2C19*1 Allele [PDF]

, 2020
openaire   +1 more source

Re: Comments on "Association of Clopidogrel Genetic Polymorphism With Efficacy and Safety for Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Updated Meta-Analysis". [PDF]

J Clin Neurol
Park H, Song TJ.
europepmc   +1 more source